SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-11-001652
Filing Date
2011-05-26
Accepted
2011-05-26 17:06:27
Documents
2
Effectiveness Date
2011-05-26

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A defa14a_052611.htm DEFA14A 20780
2 LOGO logo.gif GRAPHIC 6537
  Complete submission text file 0001171843-11-001652.txt   31035
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33560 | Film No.: 11875077
SIC: 2834 Pharmaceutical Preparations